346 related articles for article (PubMed ID: 32173973)
21. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
22. Targeting CDK12-mediated transcription regulation in anaplastic thyroid carcinoma.
Geng M; Yang Y; Cao X; Dang L; Zhang T; Zhang L
Biochem Biophys Res Commun; 2019 Dec; 520(3):544-550. PubMed ID: 31615655
[TBL] [Abstract][Full Text] [Related]
23. KLF5 promotes the tumorigenesis and metastatic potential of thyroid cancer cells through the NF-κB signaling pathway.
Ma Y; Wang Q; Liu F; Ma X; Wu L; Guo F; Zhao S; Huang F; Qin G
Oncol Rep; 2018 Nov; 40(5):2608-2618. PubMed ID: 30226614
[TBL] [Abstract][Full Text] [Related]
24. CLM29 and CLM24, pyrazolopyrimidine derivatives, have antitumoral activity in vitro in anaplastic thyroid cancer, with or without BRAF mutation.
Fallahi P; Ferrari SM; La Motta C; Materazzi G; Bocci G; Da Settimo F; Miccoli P; Antonelli A
Endocrine; 2016 Jul; 53(1):136-44. PubMed ID: 26286966
[TBL] [Abstract][Full Text] [Related]
25. LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.
Wang XM; Liu Y; Fan YX; Liu Z; Yuan QL; Jia M; Geng ZS; Gu L; Lu XB
Cancer Biol Ther; 2018 Jul; 19(7):590-597. PubMed ID: 29561707
[TBL] [Abstract][Full Text] [Related]
26. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
[TBL] [Abstract][Full Text] [Related]
27. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
[TBL] [Abstract][Full Text] [Related]
29. miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.
Shao M; Geng Y; Lu P; Xi Y; Wei S; Wang L; Fan Q; Ma W
Biochem Biophys Res Commun; 2015 Sep; 464(4):1309-1313. PubMed ID: 26231799
[TBL] [Abstract][Full Text] [Related]
30. FOXD3 regulates anaplastic thyroid cancer progression.
Yin H; Meng T; Zhou L; Zhao F; Li X; Li Y; Hu M; Chen H; Song D
Oncotarget; 2017 May; 8(20):33644-33651. PubMed ID: 28430585
[TBL] [Abstract][Full Text] [Related]
31. S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.
Reeb AN; Li W; Sewell W; Marlow LA; Tun HW; Smallridge RC; Copland JA; Spradling K; Chernock R; Lin RY
J Clin Endocrinol Metab; 2015 Feb; 100(2):E232-42. PubMed ID: 25423568
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
33. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
[TBL] [Abstract][Full Text] [Related]
34. Targeted inhibition of long non-coding RNA H19 blocks anaplastic thyroid carcinoma growth and metastasis.
Zhang H; Yu Y; Zhang K; Liu X; Dai Y; Jiao X
Bioengineered; 2019 Dec; 10(1):306-315. PubMed ID: 31299871
[TBL] [Abstract][Full Text] [Related]
35. Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.
Garg M; Kanojia D; Mayakonda A; Ganesan TS; Sadhanandhan B; Suresh S; S S; Nagare RP; Said JW; Doan NB; Ding LW; Baloglu E; Shacham S; Kauffman M; Koeffler HP
Sci Rep; 2017 Aug; 7(1):9749. PubMed ID: 28852098
[TBL] [Abstract][Full Text] [Related]
36. Effect of mesoporous silica nanoparticles co‑loading with 17‑AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2.
Wang C; Zhang R; Tan J; Meng Z; Zhang Y; Li N; Wang H; Chang J; Wang R
Oncol Rep; 2020 May; 43(5):1491-1502. PubMed ID: 32323855
[TBL] [Abstract][Full Text] [Related]
37. Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo.
Liu J; Dong BF; Wang PS; Ren PY; Xue S; Zhang XΝ; Han Z; Chen G
Oncol Rep; 2015 Mar; 33(3):1551-9. PubMed ID: 25592304
[TBL] [Abstract][Full Text] [Related]
38. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
[TBL] [Abstract][Full Text] [Related]
39. Antitumor Activity of Berberine by Activating Autophagy and Apoptosis in CAL-62 and BHT-101 Anaplastic Thyroid Carcinoma Cell Lines.
Shi XZ; Zhao S; Wang Y; Wang MY; Su SW; Wu YZ; Xiong C
Drug Des Devel Ther; 2023; 17():1889-1906. PubMed ID: 37397788
[TBL] [Abstract][Full Text] [Related]
40. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target.
von Roemeling CA; Marlow LA; Pinkerton AB; Crist A; Miller J; Tun HW; Smallridge RC; Copland JA
J Clin Endocrinol Metab; 2015 May; 100(5):E697-709. PubMed ID: 25675381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]